Jefferies analyst, Brandon Couillard is more positive on Bruker (NASDAQ: BRKR) after 1Q16 EPS of $0.21 blew away consensus of $0.06 on better operational execution, timing and a lower tax rate. BRKR's self-help initiatives continue to gain traction even though 2016/17 forecasts are largely unchanged. That said, the analyst believes there is greater likelihood of the company beating forecasts in future quarter.

PT moves to $30 (from $28). Buy maintained.

For an analyst ratings summary and ratings history on Bruker click here. For more ratings news on Bruker click here.

Shares of Bruker closed at $27.65 yesterday.